Antagonistic effect of NK cells on alternatively activated monocytes: A contribution of NK cells to CTL generation

Blood

Volumn 100, Issue 12, 2002, Pages 4049-4058

  Geldhof, Anja B ^a,b   Van Ginderachter, Jo A ^a   Liu, YuanQing ^a   Noël, Wim ^a   Raes, Geert ^a   De Baetselier, Patrick ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VIB VUB IMOL II   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENICITY; IMMUNOREGULATION; MEMORY CELL; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN CELL; T CELL LYMPHOMA; T LYMPHOCYTE SUBPOPULATION; TUMOR GROWTH; TUMOR MODEL; TUMOR REJECTION;

EID: 0036891867     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-11-0106     Document Type: Article

References (85)

1. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat Immunol. 2000;1:119-126.
2. Fernandez NC, Lozier A, Flament C, et al. Dendritic cells directly trigger NK cell functions: Crosstalk relevant in innate anti-tumor immune responses in vivo. Nat Med. 1999;5:405-411.
3. Amakata Y, Fujiyama Y, Andoh A, Hodohara K, Bamba T. Mechanism of NK cell activation induced by coculture with dendritic cells derived from peripheral blood monocytes. Clin Exp Immunol. 2001;124:214-222.
4. Nishioka Y, Nishimura N, Suzuki Y, Sone S. Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur J Immunol. 2001;31:2633-2641.
5. Yu Y, Hagihara M, Ando K, et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J Immunol. 2001; 166:1590-1600.
6. Seaman WE, Sleisenger M, Eriksson E, Koo GC. Depletion of natural killer cells in mice by monoclonal antibody to NK1.1: Reduction in host defense against malignancy without loss of cellular or humoral immunity. J Immunol. 1987;138:4539-4544.
7. Gray JG, Hirokawa M, Horwitz DA. The role of transforming growth factor β in the generation of suppression: An interaction between CD8+ T and NK cells. J Exp Med. 1994;180:1937-1942.
8. Smyth MJ, Kelly JM. Accessory function for NK1.1 + natural killer cells producing interferon-gamma in xenospecific cytotoxic T lymphocyte differentiation. Transplantation. 1999;68:840-843.
9. Novelli F, Giovarelli M, Reber-Liske R, Virgallita G, Garotta G, Forni G. Blockade of physiologically secreted IFN-gamma inhibits human T lymphocyte and natural killer cell activation. J Immunol. 1991;147:1445-1452.
10. Romagrani S. Induction of TH1 and TH2 responses: A key role for the "natural" immune response? Immunol Today. 1992;13:379-381.
11. Salazar-Mather TP, Ishikawa R, Biron CA. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol. 1996;157:3054-3064.
12. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med. 1998;187:11-14.
13. Korsgren M, Persson CG, Sundler F, et al. Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J Exp Med. 1999;189:553-562.
14. Cooper MA, Fehniger TA, Turner SC, et al. Human natural killer cells: A unique innate immunoregulatory role for the CD56(bright) subset. Blood. 2001;97:3146-3151.
15. Warschkau H, Kiderlen AF. A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J Immunol. 1999;163:3409-3416.
16. Geldhof AB, Moser M, Lespagnard L, Thielemans K, De Baetselier P. IL-12-activated NK cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood. 1998;91:196-206.
17. Chambers BJ, Salcedo M, Ljunggren HG. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity. 1996;5:311-317.
18. Djeu JY, Blanchard DK. Lysis of human monocytes by lymphokine-activated killer cells. Cell Immunol. 1988;111:55-65.
19. Gilbertson SM, Shah PD, Rowley DA. NK cells suppress the generation of Lyt-2+ cytolytic T cells by suppressing or eliminating dendritic cells. J Immunol. 1986;136:3567-3571.
20. Carbone E, Terrazzano G, Ruggiero G, et al. Recognition of autologous dendritic cells by human NK cells. Eur J Immunol. 1999;29:4022-4029.
21. Wilson JL, Charo J, Martin-Fontecha A, et al. NK cell triggering by the human costimulatory molecules CD80 and CD86. J Immunol. 1999;163:4207-4212.
22. Wilson JL, Heffler LC, Charo J, Scheynius A, Bejarano MT, Ljunggren HG. Targeting of human dendritic cells by autologous NK cells. J Immunol. 1999;163:6365-6370.
23. Parajuli P, Nishioka Y, Nishimura N, et al. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: Participation of both T cells and NK cells in the killing. J Leukoc Biol. 1999;65:764-770.
24. Spaggiari GM, Carosio R, Pende D, et al. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46. Eur J Immunol. 2001;31:1656-1665.
25. Carbone E, Terrazzano G, Melian A, et al. Inhihition of human NK cell-mediated killing by CD1 molecules. J Immunol. 2000;164:6130-6137.
26. Ferlazzo G, Semino C, Melioli G. HLA class I molecule expression is up-regulated during maturation of dendritic cells, protecting them from natural killer cell-mediated lysis. Immunol Lett. 2001;76:37-41.
27. Goerdt S, Politz O, Schledzewski K, et al. Alternative versus classical activation of macrophages. Pathobiology. 1999;67:222-226.
28. Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science. 2001;293:253-256.
29. Stein M, Keshav S, Harris N, Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: A marker of alternative immunologic macrophage activation. J Exp Med. 1992;176:287-292.
30. Goerdt S, Orfanos CE. Other functions, other genes: Alternative activation of antigen-presenting cells. Immunity. 1999;10:137-142.
31. MacDonald AS, Straw AD, Bauman B, Pearce EJ. CD8(-) dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol. 2001;167:1982-1988.
32. Abrahamsohn IA, Coffman RL. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol. 1995;155:3955-3963.
33. Allavena P, Piemonti L, Longoni D, et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol. 1998;28:359-369.
34. Enk AH, Jonuleit H, Saloga J, Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int J Cancer. 1997;73:309-316.
35. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol. 2001;166:5398-5406.
36. Kusmartsev SA, Li Y, Chen SH. Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol. 2000;165:779-785.
37. Bronte V, Chappell DB, Apolloni E, et al. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation. J Immunol. 1999;162: 5728-5737.
38. Apolloni E, Bronte V, Mazzoni A, et al. Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J Immunol. 2000;165:6723-6730.
39. Bronte V, Apolloni E, Cabrelle A, et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood. 2000;96:3838-3846.
40. k antigens. Clin Exp Metastasis. 1994;12:73-83.
41. Raes G, Van Ginderachter J, Liu Y-Q, et al. Active antitumor immunotherapy, with or without B7-mediated costimulation, increases tumor progression in an immunogenic murine T cell lymphoma model. Cancer Immunol Immunother. 1998;45:257-265.
42. Beck BN, Gillis S, Henney CS. Display of the neutral glycolipid ganglio-n-tetraosylceramide (asialo GM1) on cells of the natural killer and T lineages. Transplantation. 1982;33:118-122.
43. Stitz L, Baenziger J, Pircher H, Hengartner H, Zinkernagel RM. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J Immunol. 1986;136:4674-4680.
44. Stout RD, Schwarting GA, Suttles J. Evidence that expression of asialo-GM1 may be associated with cell activation. Correlation of asialo-GM1 expression with increased total cellular RNA and protein content in normal thymocyte and spleen cell populations. J Immunol. 1987;139:2123-2129.
45. Geldhof AB, Van Ginderachter J, Vandersteen P, Raes G, De Baetselier P. Multiple effects of transfection with interleukin 2 and/or interferon gamma on the behavior of mouse T lymphoma cells. Clin Exp Metastasis. 1998;16:447-459.
46. Wiltrout RH, Taramelli D, Holden HT. Measurement of macrophage-mediated cytotoxicity against adherent and non-adherent target cells by release of 111 indium-oxine. J Immunol Methods. 1981;43:319-331.
47. Geldhof AB, Raes G, Bakkus M, Devos S, Thielemans K, De Baetselier P. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 1995;55:2730-2733.
48. Namangala B, De Baetselier P, Noël W, Brijs L, Beschin A. Alternative versus classical macrophage activation during experimental African trypanosomosis. J Leukoc Biol. 2001;69:387-396.
49. Raes G, Geldhof A, Vanden Driessche T, Opdenakker G, Sibille C, De Baetselier P. Immunogenization of a murine T-cell lymphoma via transfection with interferon-gamma. Leukemia. 1995;9: S121-S127.
50. Smyth MJ, Kershaw MH, Darcy PK. Xenospecific CD8+ cytotoxic T lymphocyte generation: Accessory function for CD4+ T cells and natural killer 1.1 + cells. Transplantation. 1998;65:1278-1281.
51. Kos FJ, Engleman EG. Role of natural killer cells in the generation of influenza virus-specific cytotoxic T cells. Cell Immunol. 1996;173:1-6.
52. Kurosawa S, Harada M, Matsuzaki G, et al. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes. Immunology. 1995;85:338-346.
53. Terao H, Harada M, Kurosawa S, et al. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ Tcells. Immunobiology. 1996;195:172-186.
54. Kambayashi T, Assarsson E, Chambers BJ, Ljunggren HG. Expression of the DX5 antigen on CD8+ T cells is associated with activation and subsequent cell death or memory during influenza virus infection. Eur J Immunol. 2001;31:1523-1530.
55. Kambayashi T, Assarsson E, Michaelsson J, et al. Emergence of CD8+ T cells expressing NK cell receptors in influenza A virus-infected mice. J Immunol. 2000;165:4964-4969.
56. Assarsson E, Kambayashi T, Sandberg JK, et al. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. J Immunol. 2000;165:3673-3679.
57. Ting CC, Bluestone JA, Hargrove ME, Loh NN. Expression and function of asialo GM1 in allo-reactive cytotoxic T lymphocytes. J Immunol. 1986;137:2100-2106.
58. Suttles J, Schwarting GA, Stout RD. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J Immunol. 1986;136:1586-1591.
59. Peacock CD, Lin MY, Ortaldo JR, Welsh RM. The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J Virol. 2000;74:7032-7038.
60. Suzuki R, Suzuki S, Ebina N, Kumagai K. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2. J Immunol. 1985;134:2139-2148.
61. Parker SE, Sun YH, Sears DW. Differential expression of the ASGM1 antigen on anti-reovirus and alloreactive cytotoxic T lymphocytes (CTL). J Immunogenet. 1988;15:215-226.
62. Kelly JM, Darcy PK, Markby JL, et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol. 2002;3:83-90.
63. Cerwenka A, Bakker AB, McClanahan T, et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 2000;12:721-727.
64. Diefenbach A, Jensen ER, Jamieson AM, Raulet DH. Rael and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature. 2001;413:165-171.
65. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001;98:11521-11526.
66. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166-6173.
67. Munder M, Eichmann K, Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: Competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol. 1998;160:5347-5354.
68. Karpus WJ, Kennedy KJ. MIP-1alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J Leukoc Biol. 1997;62:681-687.
69. Loke P, MacDonald AS, Allen JE. Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naive CD4(+) T cells. Eur J Immunol. 2000;30:1127-1135.
70. Klein E, Mantovani A. Action of natural killer cells and macrophages in cancer. Curr Opin Immunol. 1993;5:714-718.
71. Blanchard DK, Hall RE, Djeu JY. Role of CD18 in lymphokine activated killer (LAK) cell-mediated lysis of human monocytes: Comparison with other LAK targets. Int J Cancer. 1990;45:312-319.
72. Martin-Fontecha A, Assarsson E, Carbone E, Karre K, Ljunggren HG. Triggering of murine NK cells by CD40 and CD86 (B7-2). J Immunol. 1999;162:5910-5916.
73. Geldhof AB, VandenDriessche T, Opdenakker G, De Baetselier P. Introduction of the interferon-γ gene into mouse T lymphoma cells with low MHC class I-expression results in selective induction of H-2Dk and concomitant enhanced metastasis. Cancer Immunot Immunother. 1996;42:329-338.
74. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today. 1992;13:265-270.
75. Opdenakker G, Van Damme J. Cytokines and proteases in invasive processes: Molecular similarities between inflammation and cancer. Cytokine. 1992;4:251-258.
76. Elgert KD, Alleva DG, Mullins DW. Tumor-induced immune dysfunction: The macrophage connection. J Leukoc Biol. 1998;64:275-290.
77. Bronte V, Wang M, Overwijk WW, et al. Apoptotic death of CD8+ T lymphocytes after immunization: Induction of a suppressive population of Mac-1+/Gr-1+ cells. J Immunol. 1998;161:5313-5320.
78. Kusakabe K, Xin KQ, Katoh H, et al. The timing of GM-CSF expression plasmid administration influences the Thl/Th2 response induced by an HIV-1-specific DNA vaccine. J Immunol. 2000;164:3102-3111.
79. Vassilev TL. Aluminium phosphate but not calcium phosphate stimulates the specific IgE response in guinea pigs to tetanus toxoid. Allergy. 1978;33:155-159.
80. Rook GA, Stanford JL. Give us this day our daily germs. Immunol Today. 1998;19:113-116.
81. Taylor-Robinson AW. Multiple vaccination effects on atopy. Allergy. 1999;54:398-400.
82. Hurwitz EL, Morgenstern H. Effects of diphtheriatetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther. 2000;23:81-90.
83. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000;85:9-21.
84. Strayer DR, Carter WA, Mayberry SD, Pequignot E, Brodsky I. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res. 1984;44:370-374.
85. Whiteside TL, Herbermann RB. Role of human natural killer cells in health and disease. Clin Diag Lab Immunol. 1994;1:125-133.